Adverse Drug Reactions in Clinical Practice: a Causality Assessment of a Case of Drug-Induced Pancreatitis

被引:0
作者
Farcas, Andreea [1 ]
Bojita, Marius [1 ]
机构
[1] Univ Med & Pharm, Drug Informat Res Ctr, Cluj Napoca, Romania
关键词
Adverse drug reactions; causality assessment; Naranjo probability score; HOSPITALIZED-PATIENTS; PHARMACOVIGILANCE; DEFINITIONS; TERMINOLOGY; MEDICATION; ADMISSION; IMPACT; GUIDE;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Modern therapy has changed the way diseases are controlled and has brought significant benefits. In spite of all the benefits, adverse drug reactions are a common, often preventable, cause of illness, disability and even death. Besides the intrinsic danger associated with the drug, patients might have a particular, unpredictable hypersensitivity to certain drugs, which requires careful monitoring. Different studies have shown that adverse drug reactions related hospital admissions comprise up to 10% of the total number of hospitalizations. Adverse drug reactions can be difficult and sometimes impossible to distinguish from the patient's disease as they act through the same physiological and pathological pathways. Unrecognized adverse drug reactions inflict health damage, hospital costs and may lead to prolonged hospitalization. The purpose of this paper is to review and clarify some specific terminology and to assess the likelihood that a suspected adverse drug reaction is actually due to a medicine, by outlining the information needed for recognizing an adverse drug reaction and the steps of a causality assessment of a theoretical drug-induced case of pancreatitis.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 28 条
[1]   The epidemiology of serious adverse drug reactions among the elderly [J].
Atkin, PA ;
Veitch, PC ;
Veitch, EM ;
Ogle, SJ .
DRUGS & AGING, 1999, 14 (02) :141-152
[2]   Clinical pharmacology - Special safety considerations in drug development and pharmacovigilance [J].
Atuah, KN ;
Hughes, D ;
Pirmohamed, M .
DRUG SAFETY, 2004, 27 (08) :535-554
[3]   Postmarketing surveillance and adverse drug reactions - Current perspectives and future needs [J].
Brewer, T ;
Colditz, GA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (09) :824-829
[4]   Lack of awareness of community-acquired adverse drug reactions upon hospital admission - Dimensions and consequences of a dilemma [J].
Dormann, H ;
Criegee-Rieck, M ;
Neubert, A ;
Egger, T ;
Geise, A ;
Krebs, S ;
Schneider, TH ;
Levy, M ;
Hahn, EG ;
Brune, K .
DRUG SAFETY, 2003, 26 (05) :353-362
[5]   Incidence and costs of adverse drug reactions during hospitalisation - Computerised monitoring versus stimulated spontaneous reporting [J].
Dormann, H ;
Muth-Selbach, U ;
Krebs, S ;
Criegee-Rieck, M ;
Tegeder, I ;
Schneider, HT ;
Hahn, EG ;
Levy, M ;
Brune, K ;
Geisslinger, G .
DRUG SAFETY, 2000, 22 (02) :161-168
[6]   Adverse drug reactions: definitions, diagnosis, and management [J].
Edwards, IR ;
Aronson, JK .
LANCET, 2000, 356 (9237) :1255-1259
[7]  
*EUR AG EV MED PRO, 1995, CLIN SAF DAT MAN DEF
[8]  
IREY N S, 1976, Annals of Clinical and Laboratory Science, V6, P272
[9]   Are incorrectly used drugs more frequently involved in adverse drug reactions?: A prospective study [J].
Jonville-Béra, AP ;
Béra, F ;
Autret-Leca, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (03) :231-236
[10]  
Köhler GI, 2000, INT J CLIN PHARM TH, V38, P504